Search Results - Peter G. Rose
- Showing 1 - 11 results of 11
-
1
Response of low HER2-expressing ovarian carcinosarcoma to trastuzumab deruxtecan, a case report by Peter G. Rose
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Prolonged treatment of neuroendocrine carcinoma of the cervix with a PARP inhibitor based on next generation sequencing by Peter G. Rose
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Adverse post-operative outcomes in Jehovah's witnesses with gynecologic cancer within 30 days of surgery: A single institution review of 36 cases by Laura J. Moulton, Peter G. Rose, Haider Mahdi
Published 2017Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Activity of pembrolizumab and lenvatinib in mismatch repair deficient (dMMR) endometrial cancer patients who have failed pembrolizumab monotherapy: A case series by Peter G. Rose, Myra Feldman, Iwona Podzielinski, Aaron P. Petty, Roberto Vargas
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma by Jonathan T. Hunt, Laura M. Chambers, Meng Yao, Amy Joehlin-Price, Robert Debernardo, Peter G. Rose
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Predictors of response to immune checkpoint inhibition in a real world gynecologic cancer population by Michelle L. Kuznicki, Carrie Bennett, Meng Yao, Amy Joehlin-Price, Peter G. Rose, Haider Mahdi
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma by Laura M. Chambers, Danielle Chau, Meng Yao, Anthony B. Costales, Peter G. Rose, Chad M. Michener, Robert Debernardo, Roberto Vargas
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
8
Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancer by Laura M. Chambers, Meng Yao, Molly Morton, Morgan Gruner, Anna Chichura, Anthony B. Costales, Max Horowitz, Peter G. Rose, Chad M. Michener, Robert Debernardo
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
9
LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer by Goutam Dey, Rashmi Bharti, Chad Braley, Ravi Alluri, Emily Esakov, Katie Crean-Tate, Keith McCrae, Amy Joehlin-Price, Peter G. Rose, Justin Lathia, Zihua Gong, Ofer Reizes
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
10
Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer by Elizabeth V. Connor, Caner Saygin, Chad Braley, Andrew C. Wiechert, Sheelarani Karunanithi, Katie Crean-Tate, Fadi W. Abdul-Karim, Chad M. Michener, Peter G. Rose, Justin D. Lathia, Ofer Reizes
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
11
Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors by Katie K. Crean-Tate, Chad Braley, Goutam Dey, Emily Esakov, Caner Saygin, Alexandria Trestan, Daniel J. Silver, Soumya M. Turaga, Elizabeth V. Connor, Robert DeBernardo, Chad M. Michener, Peter G. Rose, Justin Lathia, Ofer Reizes
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book